Prostate tumors positive for ERG-fusion are characterized by an upregulation of targets for the transcription factor ERG, which in turn may lead to upregulation of Polycomb genes, thus linking ERG-fusion to Polycomb repression[27]. This evidence concerns the gene ERG and prostate neoplasm.